Certara Reports First Quarter 2025 Financial Results

Reiterates Full Year 2025 Financial GuidanceRADNOR, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the first quarter of fiscal year 2025. First Quarter Highlights: Revenue was $106.0 million, compared to$96.7 million in the first quarter of 2024, representing growth of 10%. Software revenue was $46.4 million, compared to$39.3 million in the first quarter of 2024, representing growth of 18%.Ser ...